Clinical Trial Update: Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and immune response of an H7N7 influenza vaccine in healthy adults; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infl Influenza Virus Infection Subtype H7n7

Drugs mentioned

• H7N7 influenza vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza A Subtype H7N7 Infection | Phase 1 | Status: COMPLETED